CRIS Current Research Information System

RIHAWI, KARIM
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.321
AS - Asia 1.284
EU - Europa 903
Continente sconosciuto - Info sul continente non disponibili 107
AF - Africa 106
SA - Sud America 59
OC - Oceania 3
Totale 3.783
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.281
VN - Vietnam 398
IT - Italia 391
SG - Singapore 321
CN - Cina 320
DE - Germania 96
GB - Regno Unito 93
HK - Hong Kong 84
SE - Svezia 66
IN - India 48
FR - Francia 41
IE - Irlanda 40
BR - Brasile 39
NL - Olanda 37
FI - Finlandia 35
KR - Corea 34
SC - Seychelles 27
TG - Togo 27
RU - Federazione Russa 22
BG - Bulgaria 19
CA - Canada 17
JP - Giappone 17
ZA - Sudafrica 17
CI - Costa d'Avorio 16
CH - Svizzera 15
JO - Giordania 12
UA - Ucraina 11
ID - Indonesia 10
BD - Bangladesh 8
EE - Estonia 8
MX - Messico 8
TW - Taiwan 8
AR - Argentina 7
AT - Austria 7
BE - Belgio 7
CR - Costa Rica 7
NG - Nigeria 6
PH - Filippine 6
TH - Thailandia 6
EC - Ecuador 5
PL - Polonia 5
ES - Italia 4
PY - Paraguay 4
AU - Australia 3
JM - Giamaica 3
TN - Tunisia 3
UZ - Uzbekistan 3
CD - Congo 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
IQ - Iraq 2
LT - Lituania 2
PA - Panama 2
PK - Pakistan 2
SA - Arabia Saudita 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
GD - Grenada 1
GR - Grecia 1
HU - Ungheria 1
LB - Libano 1
MA - Marocco 1
PE - Perù 1
TR - Turchia 1
VE - Venezuela 1
Totale 3.676
Salva come PNG Salva come JPEG
Città #
Singapore 219
Ashburn 160
San Jose 145
Bologna 117
Hanoi 89
Ho Chi Minh City 87
Chandler 85
Hong Kong 77
Santa Clara 74
Fairfield 68
Southend 67
Hefei 61
Beijing 50
Houston 46
Woodbridge 44
Council Bluffs 41
Dublin 40
Boardman 38
Seattle 38
Dong Ket 34
Helsinki 29
Seoul 29
Wilmington 29
Princeton 28
Lomé 27
Los Angeles 24
Cambridge 23
Florence 22
Milan 21
New York 20
Sofia 19
Vicenza 18
Abidjan 16
Dallas 16
Bern 15
Haiphong 15
Lauterbourg 15
Tokyo 14
Turin 13
Amman 12
Chicago 11
Da Nang 11
Shanghai 11
Berlin 10
Redondo Beach 10
Redmond 9
Rimini 9
San Lazzaro di Savena 9
São Paulo 9
Bremen 8
Falkenstein 8
Jinan 8
Johannesburg 8
Nanjing 8
Rome 8
Westminster 8
Amsterdam 7
Ann Arbor 7
Brussels 7
Buffalo 7
Forlì 7
Frankfurt am Main 7
Munich 7
Tianjin 7
Abeokuta 6
Jakarta 6
Montreal 6
Bengaluru 5
Guangzhou 5
Hangzhou 5
Hebei 5
Ninh Bình 5
Nuremberg 5
Orem 5
Phoenix 5
Phủ Lý 5
San Diego 5
San José 5
Shenyang 5
Tân Tiến 5
Vienna 5
Visakhapatnam 5
Boydton 4
Falls Church 4
Fuzhou 4
London 4
Modena 4
Naples 4
Padova 4
Paris 4
San Francisco 4
The Dalles 4
Thái Nguyên 4
Wuhan 4
Atlanta 3
Biên Hòa 3
Boston 3
Bình Phước 3
Bühl 3
Carpi 3
Totale 2.345
Salva come PNG Salva come JPEG
Nome #
Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer 303
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary 280
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale 244
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 220
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 215
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products. 214
Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding 208
Pembrolizumab in the treatment of metastatic non-small cell lung cancer: A review of current evidence 196
MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report 191
Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins 173
Chemotherapy treatment in malignant pleural mesothelioma: A difficult history 166
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study 161
Expected and non-expected immune-related adverse events detectable by CT 153
BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience 150
Emerging therapies in malignant pleural mesothelioma 142
Pneumatosis intestinalis and spontaneous perforation associated with drug toxicity in oncologic patients: A case series 133
Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: Novel translational implications 131
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization 130
Activation of ALK Signaling Pathway Induces DNA Damage Response in Colorectal Cancer 113
Novel HER2-directed treatments in advanced gastric carcinoma: Another paradigm shift? 113
Immune checkpoint inhibition in small cell lung cancer: A key to reach an unmet need? 61
The safety and efficacy of enzalutamide in the treatment of advanced prostate cancer 50
Cancer of unknown primary genomic profiling from cell-free DNA provides insights into CUP biology and vulnerabilities 36
Totale 3.783
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.946
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.946
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022212 0 0 7 4 17 16 5 27 16 19 60 41
2022/2023537 21 54 12 56 49 68 30 35 88 13 66 45
2023/2024182 16 22 15 15 19 40 5 6 10 21 6 7
2024/2025655 12 78 51 47 102 48 67 43 12 40 49 106
2025/20261.408 166 144 96 87 129 42 187 50 271 116 66 54
2026/2027240 66 88 86 0 0 0 0 0 0 0 0 0
Totale 3.783